Comparison of investigator-delineated gross tumour volumes and quality assurance in pancreatic cancer: analysis of the on-trial cases for the SCALOP trial

Fokas, Emmanouil, Spezi, Emiliano ORCID: https://orcid.org/0000-0002-1452-8813, Patel, Neel, Hurt, Chris Nicholas ORCID: https://orcid.org/0000-0003-1206-8355, Nixon, Lisette Sheena ORCID: https://orcid.org/0000-0002-1270-6970, Chu, Kwun-Ye, Staffurth, John Nicholas ORCID: https://orcid.org/0000-0002-7834-3172, Abrams, Ross and Mukherjee, Somnath 2016. Comparison of investigator-delineated gross tumour volumes and quality assurance in pancreatic cancer: analysis of the on-trial cases for the SCALOP trial. Radiotherapy and Oncology 120 (2) , pp. 212-216. 10.1016/j.radonc.2016.07.002

PDF - Published Version Available under License Creative Commons Attribution. Download (673kB)

Abstract

Background and purpose We performed a retrospective central review of tumour outlines in patients undergoing radiotherapy in the SCALOP trial. Materials and methods The planning CT scans were reviewed retrospectively by a central review team, and the accuracy of investigators’ GTV (iGTV) and PTV (iPTV) was compared to the trials team-defined gold standard (gsGTV and gsPTV) using the Jaccard Conformity Index (JCI) and Geographical Miss Index (GMI). The prognostic value of JCI and GMI was also assessed. The RT plans were also reviewed against protocol-defined constraints. Results 60 patients with diagnostic-quality planning scans were included. The median whole volume JCI for GTV was 0.64 (IQR: 0.43–0.82), and the median GMI was 0.11 (IQR: 0.05–0.22). For PTVs, the median JCI and GMI were 0.80 (IQR: 0.71–0.88) and 0.04 (IQR: 0.02–0.12) respectively. Tumour was completely missed in 1 patient, and ⩾ 50% of the tumour was missed in 3. Patients with JCI for GTV ⩾ 0.7 had 7.12 (95% CIs: 1.83–27.67, p = 0.005) higher odds of progressing by 9 months in multivariate analysis. Major deviations in RT planning were noted in 4.5% of cases. Conclusions Radiotherapy workshops and real-time central review of contours are required in RT trials of pancreatic cancer.

Item Type:	Article
Date Type:	Published Online
Status:	Published
Schools:	Engineering Medicine
Subjects:	R Medicine > RC Internal medicine > RC0254 Neoplasms. Tumors. Oncology (including Cancer)
Uncontrolled Keywords:	Radiotherapy; Pancreas; Prospective trial; Conformity index; Quality assurance
Publisher:	Elsevier
ISSN:	0167-8140
Funders:	Cancer Research UK
Date of First Compliant Deposit:	16 December 2016
Date of Acceptance:	3 July 2016
Last Modified:	21 Oct 2023 01:10
URI:	https://orca.cardiff.ac.uk/id/eprint/96965

Citation Data

Cited 10 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item